Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00001975 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Skin Tumors in Tuberous Sclerosis

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 408 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fields
  2. Minor Re-verified, no change to tracked fields
  3. Minor Re-verified, no change to tracked fields
  4. Minor New version filed on ClinicalTrials.gov
  5. Minor 46 versions Re-verified since Mar 19, 2025, no change to tracked fieldsv359-v404
Tuberous sclerosis is a rare, hereditary disease in which patients develop multiple tumors. Although not cancerous, the tumors can affect various organs, including the heart, lungs, kidneys, skin, and central nervous system, with serious medical consequences. The severity of disease varies greatly among patients, from barely detectable to fatal. This study will investigate what causes skin tumors to develop in patients with this disease. Patients with tuberous sclerosis 18 years and older may enroll in this study. Participants will undergo a medical history and thorough skin examination by a dermatologist. Those with skin tumors will be asked to undergo biopsy (tissue removal) of up to eight lesions, under a local anesthetic, for research purposes. The biopsies will all be done the same day. The tissue samples will be used for: examination of genetic changes, measurement of certain proteins and other substances, and growing in culture to study the genetics of tuberous sclerosis. ...
Trial Details
NCT Number NCT00001975
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Collaborators: Uniformed Services University of the Health Sciences
Conditions
(from sponsor)
Tuberous Sclerosis
Related terms Neoplastic Syndromes, Hereditary, Tuberous Sclerosis
Enrollment 400 participants
Start Date
Updated on ClinicalTrials.gov